Novel pathways in T lymphocyte differentiation and function
T 淋巴细胞分化和功能的新途径
基本信息
- 批准号:RGPIN-2015-05491
- 负责人:
- 金额:$ 2.11万
- 依托单位:
- 依托单位国家:加拿大
- 项目类别:Discovery Grants Program - Individual
- 财政年份:2018
- 资助国家:加拿大
- 起止时间:2018-01-01 至 2019-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The ability to generate high-affinity antibodies to diverse infectious agents (i.e. humoral immunity) is a fundamental property of the vertebrate immune system and ensures host survival. The humoral immune response requires highly coordinated interactions between B lymphocytes (which possess antibody-producing potential) and "helper" T cells. These interactions are mediated by a subset of helper T cells termed T follicular helper (Tfh) cells that provide direct help to B cells through provision of membrane-bound co-stimulatory molecules and secretion of polarizing cytokines. We have previously shown that Tfh cells provide critical sources of interleukin (IL)-4 and IL-21 required for the generation of humoral immune responses in the context of immunization (King et al, Nature Immunology, 2012) and parasitic helminth infection (King and Mohrs, Journal of Experimental Medicine, 2009). This proposal builds on these findings to identify previously undescribed molecules and signaling pathways that specifically control T cell differentiation and function.***To discover molecules uniquely expressed by Tfh cells, we performed preliminary experiments using microarray technology comparing this subset to other CD4+ T cell subsets isolated from the inflamed mesenteric lymph nodes of mice infected with an intestinal helminth. Our results indicate that Tfh cells express high levels of CD109 compared to other CD4+ T cells. CD109 is a glycophosphatidylinositol-anchored protein with unknown function in the immune system. Functional studies using keratinocytes have demonstrated that CD109 acts as a negative regulator of transforming growth factor (TGF)-b1 signaling, a cytokine that dramatically influences T effector cell differentiation. Preliminary results from my laboratory indicate that key TGF-b1 target genes such as SMAD7 are downregulated in Tfh cells, findings consistent with the idea that CD109 is also negatively regulating this signaling pathway in T cells. In addition, CD109 has been been shown to regulate STAT3, a transcription factor that promotes Tfh cell differentiation as well as other T effector subsets. Thus, an in-depth analysis of CD109 in T cell biology and its potential relationship to TGF-b1 and STAT3-dependent signaling in lymphocytes is warranted. In this application, we propose a research program to elucidate the function of CD109 in T cell activation and its specificity in controlling T cell differentiation and function by pursuing 3 specific objectives:******1. Identify the requirements for CD109 expression by CD4+ T cells.***2. Determine how CD109 impacts CD4+ T cell activation and differentiation. ***3. Identify CD109 binding partners in activated CD4+ T cells. ******Understanding the function of CD109 in T cell differentiation and/or function will provide new insight into the molecular mechanisms controlling this important immune cell population.**
产生针对不同感染因子的高亲和力抗体(即体液免疫)的能力是脊椎动物免疫系统的基本特性,并确保宿主存活。体液免疫反应需要B淋巴细胞(具有抗体产生潜力)和“辅助”T细胞之间高度协调的相互作用。这些相互作用由称为T滤泡辅助(Tfh)细胞的辅助性T细胞亚群介导,所述辅助性T细胞通过提供膜结合共刺激分子和分泌极化细胞因子而向B细胞提供直接帮助。我们先前已经表明,Tfh细胞提供了在免疫(King等,Nature Immunology,2012)和寄生蠕虫感染(King和Mohrs,Journal of Experimental Medicine,2009)的背景下产生体液免疫应答所需的白介素(IL)-4和IL-21的关键来源。该提案建立在这些发现的基础上,以确定以前未描述的分子和信号通路,这些分子和信号通路特异性地控制T细胞分化和功能。为了发现Tfh细胞独特表达的分子,我们使用微阵列技术进行了初步实验,将该亚群与从感染肠道蠕虫的小鼠的发炎肠系膜淋巴结分离的其他CD 4 + T细胞亚群进行比较。我们的研究结果表明,Tfh细胞表达高水平的CD 109相比,其他CD 4 + T细胞。CD 109是一种糖磷脂酰肌醇锚定蛋白,在免疫系统中具有未知功能。使用角质形成细胞的功能研究表明,CD 109作为转化生长因子(TGF)-β 1信号传导的负调节剂,一种细胞因子,显着影响T效应细胞分化。我实验室的初步结果表明,关键的TGF-β 1靶基因,如SMAD 7在Tfh细胞中下调,这一发现与CD 109也在T细胞中负调节这一信号通路的观点一致。此外,CD 109已被证明可以调节STAT 3,STAT 3是一种促进Tfh细胞分化以及其他T效应子亚群的转录因子。因此,深入分析CD 109在T细胞生物学中的作用及其与TGF-b1和STAT 3依赖的淋巴细胞信号传导的潜在关系是必要的。在本申请中,我们提出了一个研究计划,以阐明CD 109在T细胞活化中的功能及其在控制T细胞分化和功能中的特异性,通过追求3个具体目标:**1.确定CD 4 + T细胞表达CD 109的要求。* 2.确定CD 109如何影响CD 4 + T细胞活化和分化。*3。鉴定活化的CD 4 + T细胞中的CD 109结合伴侣。** 了解CD 109在T细胞分化和/或功能中的功能将为控制这一重要免疫细胞群体的分子机制提供新的见解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
King, Irah其他文献
King, Irah的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('King, Irah', 18)}}的其他基金
Novel pathways in T lymphocyte differentiation and function
T 淋巴细胞分化和功能的新途径
- 批准号:
RGPIN-2015-05491 - 财政年份:2021
- 资助金额:
$ 2.11万 - 项目类别:
Discovery Grants Program - Individual
Novel pathways in T lymphocyte differentiation and function
T 淋巴细胞分化和功能的新途径
- 批准号:
RGPIN-2015-05491 - 财政年份:2020
- 资助金额:
$ 2.11万 - 项目类别:
Discovery Grants Program - Individual
Novel pathways in T lymphocyte differentiation and function
T 淋巴细胞分化和功能的新途径
- 批准号:
RGPIN-2015-05491 - 财政年份:2019
- 资助金额:
$ 2.11万 - 项目类别:
Discovery Grants Program - Individual
Novel pathways in T lymphocyte differentiation and function
T 淋巴细胞分化和功能的新途径
- 批准号:
RGPIN-2015-05491 - 财政年份:2017
- 资助金额:
$ 2.11万 - 项目类别:
Discovery Grants Program - Individual
Novel pathways in T lymphocyte differentiation and function
T 淋巴细胞分化和功能的新途径
- 批准号:
RGPIN-2015-05491 - 财政年份:2016
- 资助金额:
$ 2.11万 - 项目类别:
Discovery Grants Program - Individual
Novel pathways in T lymphocyte differentiation and function
T 淋巴细胞分化和功能的新途径
- 批准号:
RGPIN-2015-05491 - 财政年份:2015
- 资助金额:
$ 2.11万 - 项目类别:
Discovery Grants Program - Individual
相似国自然基金
4-半乳糖基转移酶调控肝内胆管癌发生的机制研究
- 批准号:2024JJ5284
- 批准年份:2024
- 资助金额:0.0 万元
- 项目类别:省市级项目
StPSR1基因调控马铃薯块茎发育的机制初探
- 批准号:n/a
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
水稻条斑病细菌hrp调控系统对致病性效应分子调控的分子机理
- 批准号:30370926
- 批准年份:2003
- 资助金额:21.0 万元
- 项目类别:面上项目
相似海外基金
Development of first-in-class antagonists of the retinoid pathway as novel oral immunotherapies for solid cancers
开发类视黄醇途径的一流拮抗剂作为实体癌的新型口服免疫疗法
- 批准号:
10604218 - 财政年份:2023
- 资助金额:
$ 2.11万 - 项目类别:
Novel mechanisms protecting the gut from TNF
保护肠道免受 TNF 侵害的新机制
- 批准号:
10752940 - 财政年份:2023
- 资助金额:
$ 2.11万 - 项目类别:
Development of a novel adjuvant strategy enabled by modulation of the physical properties of fungal mannans
通过调节真菌甘露聚糖的物理特性开发新型佐剂策略
- 批准号:
10338399 - 财政年份:2021
- 资助金额:
$ 2.11万 - 项目类别:
Talking Back: leveraging dysfunctional osteoclasts to identify novel pathways of osteoclast-osteoblast communication
反击:利用功能失调的破骨细胞来识别破骨细胞-成骨细胞通讯的新途径
- 批准号:
10218407 - 财政年份:2021
- 资助金额:
$ 2.11万 - 项目类别:
Development of a novel adjuvant strategy enabled by modulation of the physical properties of fungal mannans
通过调节真菌甘露聚糖的物理特性开发新型佐剂策略
- 批准号:
10490881 - 财政年份:2021
- 资助金额:
$ 2.11万 - 项目类别:
Development of a novel adjuvant strategy enabled by modulation of the physical properties of fungal mannans
通过调节真菌甘露聚糖的物理特性开发新型佐剂策略
- 批准号:
10687182 - 财政年份:2021
- 资助金额:
$ 2.11万 - 项目类别:
Immunomodulatory Effects of Targeting DNA Repair with Novel Temozolomide Combinations in Colorectal Cancer
新型替莫唑胺组合靶向 DNA 修复对结直肠癌的免疫调节作用
- 批准号:
10462786 - 财政年份:2021
- 资助金额:
$ 2.11万 - 项目类别:
Therapeutic targeting of multiple glioblastoma phagocytosis checkpoints using a novel bispecific antibody
使用新型双特异性抗体靶向治疗多个胶质母细胞瘤吞噬检查点
- 批准号:
10428596 - 财政年份:2021
- 资助金额:
$ 2.11万 - 项目类别:
Immunomodulatory Effects of Targeting DNA Repair with Novel Temozolomide Combinations in Colorectal Cancer
新型替莫唑胺组合靶向 DNA 修复对结直肠癌的免疫调节作用
- 批准号:
10675088 - 财政年份:2021
- 资助金额:
$ 2.11万 - 项目类别:
Therapeutic targeting of multiple glioblastoma phagocytosis checkpoints using a novel bispecific antibody
使用新型双特异性抗体靶向治疗多个胶质母细胞瘤吞噬检查点
- 批准号:
10212046 - 财政年份:2021
- 资助金额:
$ 2.11万 - 项目类别: